1. Home
  2. KRRO vs MBI Comparison

KRRO vs MBI Comparison

Compare KRRO & MBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRRO
  • MBI
  • Stock Information
  • Founded
  • KRRO 2014
  • MBI 1973
  • Country
  • KRRO United States
  • MBI United States
  • Employees
  • KRRO N/A
  • MBI N/A
  • Industry
  • KRRO Biotechnology: Pharmaceutical Preparations
  • MBI Property-Casualty Insurers
  • Sector
  • KRRO Health Care
  • MBI Finance
  • Exchange
  • KRRO Nasdaq
  • MBI Nasdaq
  • Market Cap
  • KRRO 209.6M
  • MBI 228.2M
  • IPO Year
  • KRRO 2019
  • MBI 1987
  • Fundamental
  • Price
  • KRRO $11.42
  • MBI $4.41
  • Analyst Decision
  • KRRO Strong Buy
  • MBI Buy
  • Analyst Count
  • KRRO 7
  • MBI 2
  • Target Price
  • KRRO $85.67
  • MBI $6.25
  • AVG Volume (30 Days)
  • KRRO 89.6K
  • MBI 269.9K
  • Earning Date
  • KRRO 05-07-2025
  • MBI 05-08-2025
  • Dividend Yield
  • KRRO N/A
  • MBI N/A
  • EPS Growth
  • KRRO N/A
  • MBI N/A
  • EPS
  • KRRO N/A
  • MBI N/A
  • Revenue
  • KRRO $4,821,000.00
  • MBI $37,000,000.00
  • Revenue This Year
  • KRRO $20.96
  • MBI N/A
  • Revenue Next Year
  • KRRO N/A
  • MBI N/A
  • P/E Ratio
  • KRRO N/A
  • MBI N/A
  • Revenue Growth
  • KRRO N/A
  • MBI 285.71
  • 52 Week Low
  • KRRO $11.00
  • MBI $3.22
  • 52 Week High
  • KRRO $98.00
  • MBI $7.46
  • Technical
  • Relative Strength Index (RSI)
  • KRRO 34.02
  • MBI 46.89
  • Support Level
  • KRRO $14.54
  • MBI $4.13
  • Resistance Level
  • KRRO $16.68
  • MBI $5.00
  • Average True Range (ATR)
  • KRRO 1.49
  • MBI 0.25
  • MACD
  • KRRO -0.33
  • MBI 0.01
  • Stochastic Oscillator
  • KRRO 6.24
  • MBI 32.18

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

About MBI MBIA Inc.

MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.

Share on Social Networks: